Financial Trends -- 5/10

MP Materials is at a financial inflection point. Revenue recovered +35% YoY in FY2025 to $275M, with Q4 2025 reaching $104M (highest since 2022 commodity peak). The DoW price protection agreement added $51M in PPA income, immediately turning Q4 Adjusted EBITDA positive at $43M after 7 negative quarters. However, FCF worsened to ($304M) -- the worst in company history -- driven by negative operating cash flow and heavy investment-phase capex. GAAP EPS deteriorated to ($0.97) with 8.7% share dilution. This is a commodity-driven, investment-phase business where trailing financials are poor but the forward trajectory is clearly improving. Weight: 25%
FY2025 Revenue
$275M
+35% YoY | Q4 at $104M
Q4 2025 Adj EBITDA
$43M
Positive after 7 negative quarters
FY2025 NdPr Production
2,599 MT
+109% YoY | Toward 6,000 MT target
FY2025 FCF
($304M)
Worst ever | Investment phase
Revenue Trajectory (USD K, Quarterly)
Q4 2025 revenue inflection: $104M GAAP + $51M PPA = $155M economic revenue. Revenue bottomed in Q2 2024 at $31M as rare earth prices collapsed. The recovery to $104M in Q4 2025 reflects NdPr separation ramp and improving concentrate pricing. Including PPA income (the DoW price floor difference), economic revenue reached $155M -- a run rate that, if sustained, would approach the 2022 commodity peak. Annual revenue of $275M was still -48% below 2022 peak of $528M, but the trajectory is clearly inflecting upward.
MetricQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue ($K)$48,684K$31,258K$62,927K$60,986K$60,810K$57,393K$53,553K$103,701K
PPA Income ($K)$51,016K
Economic Rev ($K)$48,684K$31,258K$62,927K$60,986K$60,810K$57,393K$53,553K$154,717K
FY2024: $204M | FY2025: $275M (+35%). Economic revenue (incl PPA): $326M. Data sourced from Daloopa.

Annual Revenue and Adjusted EBITDA ($K)
Revenue and EBITDA are commodity-driven -- peak-to-trough swings are massive. FY2022 was the commodity supercycle peak: $528M revenue and $381M EBITDA on NdPr prices above $11K/MT. The subsequent price collapse drove revenue down -52% in FY2023 and a further -20% in FY2024. EBITDA went from $381M to ($70M) -- a $451M swing. FY2025 showed recovery (+35% revenue) but EBITDA remained negative at ($32M) on a full-year basis. The new PPA floor fundamentally changes the downside profile going forward.
MetricFY2020FY2021FY2022FY2023FY2024FY2025
Revenue ($K)$67,695K$331,952K$527,510K$253,445K$203,855K$275,457K
Rev YoY390%59%-52%-20%35%
Adj EBITDA ($K)($8,744K)$198,239K$381,104K$31,660K($70,133K)($32,393K)
Op Income ($K)($34,703K)$165,345K$327,411K($17,719K)($169,426K)($149,374K)
Net Income ($K)($28,731K)$124,042K$252,523K($48,137K)($134,116K)($168,259K)
Diluted EPS$-0.23$0.70$1.43$-0.28$-0.77$-0.97
OCF ($K)$3,277K$101,971K$343,514K$62,699K$13,349K($155,755K)
Capex ($K)($22,370K)($119,488K)($321,465K)($259,097K)($186,322K)($148,175K)
FCF ($K)($19,093K)($17,517K)$22,049K($196,398K)($172,973K)($303,930K)
Revenue peaked at $528M in FY2022 (NdPr supercycle). EBITDA negative in FY2024-FY2025. Data sourced from Daloopa.

Adjusted EBITDA -- Quarterly Inflection
EBITDA turned positive in Q4 2025 at $43M after 7 consecutive negative quarters. The Q4 EBITDA inflection was driven by $51M PPA income from the DoW agreement (effective Oct 1, 2025) and improving NdPr unit economics. Q4 2024 was barely positive at $0.8M, so the improvement represents a $42M step-function gain. Operating loss also narrowed sharply to just ($3.7M) in Q4 2025 vs. ($44M) in Q4 2024. The PPA creates a structural floor that should keep quarterly EBITDA positive even at depressed NdPr market prices.
MetricQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Adj EBITDA ($K)($22,155K)($32,979K)($15,756K)$757K($27,613K)($21,613K)($25,117K)$42,950K
Op Income ($K)($32,432K)($53,492K)($39,540K)($43,962K)($34,778K)($43,882K)($67,023K)($3,691K)
Revenue ($K)$48,684K$31,258K$62,927K$60,986K$60,810K$57,393K$53,553K$103,701K
Q4 2025 Adj EBITDA includes $51M PPA income. 7 consecutive negative quarters Q1 2024 - Q3 2025. Data sourced from Daloopa.

Production KPIs -- NdPr Ramp is the Key Driver
NdPr production doubled in FY2025 to 2,599 MT, exiting at ~4,000 MT annualized. The Stage II NdPr separation ramp is the most important operational driver. Production went from 128 MT in Q1 2024 to 718 MT in Q4 2025 -- a 5.6x increase. The company is on track toward its 6,000 MT/yr target (expected toward end of 2026). REO upstream production hit a record 50,692 MT in FY2025 (+12% YoY), progressing toward the 60K MT target. Monthly production records were set consistently through 2025.
MetricQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
REO Production (MT)11,506 MT10,695 MT11,879 MT11,375 MT12,490 MT13,145 MT13,254 MT11,803 MT
NdPr Production (MT)128 MT261 MT378 MT477 MT563 MT597 MT721 MT718 MT
NdPr Sales (MT)196 MT213 MT300 MT409 MT338 MT471 MT567 MT584 MT
NdPr Price ($/KG)$60.00/kg$55.40/kg$56.95/kg$58.77/kg$49.17/kg$49.86/kg$53.42/kg$57.34/kg
NdPr production: FY2024 1,244 MT -> FY2025 2,599 MT (+109%). Target 6,000 MT/yr by late 2026. Data sourced from Daloopa.

NdPr Realized Price ($/KG) -- PPA Floor Changes Economics
The $110/kg PPA floor is transformational -- effectively doubles realized pricing. NdPr realized price bottomed at $49.17/kg in Q1 2025, well below the $110/kg PPA floor established by the DoW agreement (effective Oct 1, 2025). The PPA covers both sold products AND stockpiled concentrate, paying the difference between market price and $110. Q4 2025 realized price was $57.34/kg, meaning the PPA contributed ~$53/kg per unit. Management noted NdPr pricing "climbed significantly" in recent weeks, approaching the $110 level. When market price rises toward $110, PPA benefit narrows but revenue rises -- net positive either way.
PPA effective Oct 1, 2025. $51M PPA income in Q4 2025. NdPr market pricing approaching $110 as of Q4 2025 call. Data sourced from Daloopa.

Free Cash Flow (Annual) -- Investment Phase Burn
FCF at ($304M) in FY2025 -- worst in company history and worsening. FCF has been negative every year except FY2022 (the commodity supercycle peak). FY2025 was the worst at ($304M), driven by negative operating CF ($156M outflow from working capital build) plus $148M capex. Capex actually declined from $259M (FY2023) to $148M (FY2025), but operating CF turned sharply negative due to NdPr tolling channel ramp and inventory stockpiling under the DoW agreement. Critically, FY2026 capex is guided at $500-600M for the 10X magnetics facility build-out, meaning FCF will likely remain deeply negative. The ~$2B cash balance provides runway but the burn rate is severe.
MetricFY2020FY2021FY2022FY2023FY2024FY2025
OCF ($K)$3,277K$101,971K$343,514K$62,699K$13,349K($155,755K)
Capex ($K)($22,370K)($119,488K)($321,465K)($259,097K)($186,322K)($148,175K)
FCF ($K)($19,093K)($17,517K)$22,049K($196,398K)($172,973K)($303,930K)
FCF negative every year except FY2022. FY2026E capex guided $500-600M (10X build). ~$2B cash on balance sheet. Data sourced from Daloopa.

New Revenue Streams: Magnetics Segment
Magnetics Segment FY2024 FY2025
Revenue $0 $66.9M
Segment EBITDA $0 $26.4M
Independence Facility Construction Producing magnets (commercial-scale)
10X Facility (Northlake, TX) Site selected, $200M+ incentives, groundbreaking imminent
Apple Partnership $200M prepayments + $500M+ contracted magnets from 2027
GM Qualification Underway, initial deliveries H2 2026
Magnetics segment generated $66.9M revenue and $26.4M EBITDA in FY2025 -- from zero. This is the Stage III story: moving from rare earth concentrate/oxide to finished NdFeB magnets. Revenue came primarily from NdPr metal precursor sales. The Independence facility is producing magnets on commercial-scale equipment, with GM qualification underway. The 10X facility in Northlake, TX will be the scaled production plant ($500-600M capex in FY2026). Apple committed $200M in milestone prepayments for recycling + Independence expansion, plus $500M+ in contracted magnet purchases from 2027. Grain boundary diffusion breakthrough reduces heavy rare earth content by 60%, improving cost structure.
Magnetics segment new in FY2025. Apple: $40M received Q3 2025, $32M earned Q4 2025. Data sourced from Daloopa.

Capital Structure and Cash Position
Item Amount Notes
Cash on Balance Sheet ~$2.0B Post DoD investment + equity offering (Q2 2025)
DoD Convertible Preferred $400M Further dilution risk from warrant/conversion
DoD Low-Interest Loan $150M Government-backstopped
Apple Prepayments $200M Milestone-based ($40M received Q3, $32M earned Q4)
FY2026E Capex Guide $500-600M Primarily 10X build-out
Shares Outstanding 177.4M +8.7% YoY dilution (163.2M -> 177.4M)
Well-funded at ~$2B cash, but burn rate of $300M+/yr with capex ramping. The balance sheet can fund the 10X build-out, but at FY2025 FCF burn of ($304M) and FY2026 capex guided at $500-600M, the runway is finite. The 8.7% share dilution in FY2025 is a real cost. Government backing (DoD preferred + loan) and Apple prepayments de-risk funding, but investors should expect continued cash consumption through at least FY2027 as the magnetics facility ramps.
Cash position as of Q4 2025. DoD convertible preferred carries further dilution risk. Data sourced from Daloopa.

Acceleration / Deceleration Analysis
Signal Detail Direction
NdPr Production Doubled to 2,599 MT in FY2025 (+109%); exiting at ~4,000 MT annualized run rate toward 6,000 MT target Accelerating
Q4 EBITDA Inflection $43M positive after 7 negative quarters; PPA creates structural floor for profitability Inflecting
Revenue Recovery +35% YoY FY2025; Q4 2025 at $104M (highest since 2022 peak); new magnetics segment adding $67M Recovering
REO Production Record 50,692 MT (+12% YoY); progressing toward Upstream 60K target Accelerating
Operating Loss Q4 2025 op loss just ($3.7M) vs. ($44M) in Q4 2024 -- narrowing sharply Improving
FCF Burn ($304M) in FY2025 vs. ($173M) in FY2024 -- worst ever; FY2026 capex guided $500-600M Worsening
Operating Cash Flow Turned negative at ($156M) in FY2025 vs. +$13M in FY2024; working capital drag Deteriorating
NdPr Pricing Realized $52.76/kg avg FY2025 vs. $58.27 FY2024; Q4 recovering to $57.34; PPA floor at $110 Mixed
GAAP EPS ($0.97) in FY2025 vs. ($0.77) FY2024 -- 3 consecutive years of losses Deteriorating
Share Dilution +8.7% dilution (163.2M to 177.4M); further risk from DoD convertible warrant Negative
Backward-looking financials are poor; forward-looking trajectory clearly improving. Data sourced from Daloopa.

Score Rationale: 5/10
Factor Impact Detail
Base Score 5 Investment-phase company with mixed financial trends
NdPr production doubling +1 Clear path to 6,000 MT target
PPA / EBITDA inflection +1 Step-function improvement; Q4 EBITDA positive at $43M
Magnetics segment EBITDA +0.5 $66.9M revenue, $26.4M EBITDA from zero
Record REO production +0.5 50,692 MT approaching 60K target
Deeply negative FCF -2 ($304M) worst ever; negative every year except FY2022
Sustained GAAP losses + dilution -0.5 3 years of losses; 8.7% dilution in FY2025
Revenue below peak -0.5 -48% from FY2022 peak even including PPA
Net Score #C0392B Positive factors (+3) offset by negative factors (-3)
A tale of two stories: poor trailing financials vs. clear forward inflection. The backward-looking numbers are poor: three consecutive years of operating losses, FCF at its worst level ever, share dilution, and revenue well below the 2022 peak. But the forward trajectory shows NdPr production doubling, PPA creating an earnings floor that immediately turned Q4 EBITDA positive, magnetics segment generating real revenue/EBITDA, and a well-funded balance sheet. The score of 5 reflects a company at the exact turning point -- financial trends transitioning from negative to positive, but only one quarter of PPA data to verify the impact and severe FCF burn from 10X investment.
Data sourced from Daloopa (company_id: 22547) and MP Materials earnings call transcripts (Q3 2024 - Q4 2025).